Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Aug 26;7(16):2393-2400.
doi: 10.12998/wjcc.v7.i16.2393.

Pseudothrombus deposition accompanied with minimal change nephrotic syndrome and chronic kidney disease in a patient with Waldenström's macroglobulinemia: A case report

Affiliations
Case Reports

Pseudothrombus deposition accompanied with minimal change nephrotic syndrome and chronic kidney disease in a patient with Waldenström's macroglobulinemia: A case report

Mercy Julian Mwamunyi et al. World J Clin Cases. .

Abstract

Background: Waldenström's macroglobulinemia (WM) is a rare lymphoid neoplasia, which can have renal complications. These rarely occur, and most common renal manifestations are mild proteinuria and microscopic hematuria. Herein we describe a case of WM that presented with pseudothrombi depositing in capillaries associated with minimal change nephrotic syndrome and chronic kidney disease (CKD).

Case summary: A 52-year-old man presented with features suggesting nephrotic syndrome. Extensive workups were done, and there were elevated serum levels of interleukin-6 and vascular endothelial growth factor (VEGF), capillary pseudothrombus accumulation associated with minimal change nephrotic syndrome, CKD, and WM. Treatment was directed at the patient's WM with bortezomib, thalidomide, and dexamethasone whereby serum immunoglobulin M (IgM) decreased. The damage of IgM on the kidney was corrected; thus, the patient's proteinuria and serum creatinine had improved. The patient is still under clinical follow-up.

Conclusion: It is essential for clinicians to promptly pay more attention to patients presenting with features of nephrotic syndrome and do extensive workups to come up with a proper therapy strategy.

Keywords: Case report; Chronic kidney disease; Nephrotic syndrome; Pseudothrombi; Waldenström's macroglobulinemia.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Light microscopy. The volume of residual glomeruli increased, the number of cells was 80-120 per glomerulus, mesangial cells and mesangial matrix were slightly increased, capillary loops were open, and the number of infiltrating cells was < 3 per glomeruli, mainly mononuclear cells. Red blood cells and “pseudothrombi” could be seen in several capillaries. One capillary loop was embedded into the urinary pole (HE staining; magnification, ×600).
Figure 2
Figure 2
Light microscopy. Periodic Schiff-Methenamine (PASM) and Masson staining. Fuchsinophilic depositions were found in the basement membrane and under the endothelium. The tubulointerstitium exhibited moderate lesions, with acute lesions on chronic damage. There was diffuse turbidity and granular degeneration in the tubular epithelial cells. Partial tubular epithelial cells presented small and fine vacuolar degeneration, and the basement membrane of tubules became thicker. Brush border of the tubules was absent. Protein casts could be seen in some lumens. The renal interstitial region could be found to be focally enlarged, and fibrosis index was 1+. Individual arterioles presented segmental hyalinosis (PASM and Masson staining; magnification, ×400).
Figure 3
Figure 3
Electron microscopy. Extensive effacement of podocyte foot processes, slight hyperplasia of mesangial matrix, and small amounts of electron dense depositions were observed in the mesangial area. Interstitial fibrosis of the kidney was obvious, and inflammatory cell infiltration was seen.

References

    1. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30:110–115. - PubMed
    1. Gnemmi V, Leleu X, Provot F, Moulonguet F, Buob D. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia. Am J Kidney Dis. 2012;60:487–491. - PubMed
    1. Grabe DW, Li B, Haqqie SS. A Case of Nephrotic Syndrome With Minimal-Change Disease and Waldenstrom's Macroglobulinemia. J Clin Med Res. 2013;5:481–483. - PMC - PubMed
    1. Mazzucchelli M, Frustaci AM, Deodato M, Cairoli R, Tedeschi A. Waldenstrom's Macroglobulinemia: An Update. Mediterr J Hematol Infect Dis. 2018;10:e2018004. - PMC - PubMed
    1. Isaac J, Herrera GA. Cast nephropathy in a case of Waldenström's macroglobulinemia. Nephron. 2002;91:512–515. doi: 10.1159/000064299. - DOI - PubMed

Publication types